Antibiotice Sa · BVB:ATB
Antibiotice Sa — Investor Presentation (September 2023)
16 slides from Antibiotice Sa's investor presentation, September 2023
Slide 1: “Future together” 2030
“Future together” 2030 Antibiotice ere
Slide 2: Romanian tradition and continuity
Romanian tradition and continuity • Only a decade after the synthesis of Penicillin, Antibiotice starts operating, being the first manufacturer of this active substance in Romania and South-East Europe. • Development of the manufacturing structure, especially for active substances, sterile powders f
Slide 3: Antibiotice – a profitable company for investors
Write it here Antibiotice – a profitable company for investors Structure of Antibiotice shareholding 26 years since the listing on the Bucharest 4.6977% Stock Exchange 12.8697% 980 million lei - traded shares 29.4153% 53.0173% Stock market capitalization 474 million lei * Average price: 0.5854 lei/s
Slide 4: Antibiotice - a company focused on knowledge and development
Write it here Antibiotice - a company focused on knowledge and development Academia a+ The multidisciplinary R & D team with 100 Center for recruitment and vocational training specialists with a degree in various fields offers future professionals the opportunity to develop their skills and acquire
Slide 5: Antibiotice - a company worth working for
Write it here Antibiotice - a company worth working for Valuable staff Oriented towards knowledge, • 1,345 employees innovation and performance • 3 generations • diversity of professions • equal opportunities Secondary education professionals (52%) Higher education professionals (48%) Chemical engin
Slide 6: Antibiotice – In the service of life for a lifetime!
Antibiotice – In the service of life for a lifetime! Write it here 1.12% 0.12% 2.59% S1 2023 Portfolio comprising 3.53% 166 products from 3.66% 11 therapeutic classes 50% 6.14% 8.23% 5% 10.63% 63.98% 10% J-Anti-infectives for systemic use C-Cardiovascular system M-Musculoskeletal system G-Genitourin
Slide 7: Antibiotice - a balanced and dynamic manufacturing structure
Write it here Antibiotice - a balanced and dynamic manufacturing structure 3 manufacturing 8 manufacturing 10 manufacturing divisions flows partner sites Production made in the first half of 2023 on our own sites recorded a value of 355.6 million lei, higher by 9.7% compared to the production record
Slide 8: Antibiotice - a performance-focused company
Antibiotice - a performance-focused company Write it here PERFORMANCE IN THE DOMESTIC MARKET PERFORMANCE IN THE FOREIGN MARKET Turnover in the international markets • present in all over 500 hospitals and over 5,000 119.8 million lei pharmacies in Romania; +25.7% ▪ the market sales amounted to 257.5
Slide 9: Antibiotice, a company of international standards
Write it here Antibiotice, a company of international standards EU GMP 8 manufacturing flows US FDA Sterile powders for injection and Nystatin active substance COS (Certificate of Suitability) issued by EDQM Standard and micronized nystatin ISO TUV RHEINLAND certified for the integrated management Q
Slide 10: Antibiotice, an internationally recognized Romanian brand
Write it here Antibiotice, an internationally recognized Romanian brand Breakdown of international sales World leader in the production of Nystatin Europa 27% America de Nord 33% Asia 25% Africa si Orientul Mijlociu 6% America de Sud 8% Australia 1% Partners in target countries for export developmen
Slide 11: Antibiotice – future business dynamics
Write it here Antibiotice – future business dynamics Business Plan 2023 → 2030 – ,,The Future Together” - Goals 01 02 03 04 05 06 Well-balanced Physical market Turnover Profitability Average net Labour capitalization of share in Romania income per productivity manufacturing facilities - boxes employ
Slide 12: Antibiotice - future business dynamics
Antibiotice - future business dynamics Write it here INDICATOR U.M. 2022 2023 2024 2025 2027 2030 TOTAL INCOME mil Lei 535 592 692 818 1,038 1,292 GROSS TURNOVER, of which mil Lei 600 700 811 929 1,175 1,457 Romania mil Lei 413 487 567 649 819 1,033 International mil Lei 186 212 244 281 356 425 Curr
Slide 13: Antibiotice, a sustainable investment
Write it here Antibiotice, a sustainable investment Strategic investments Investments 2010 – 2022 2023-2030 380 million lei 400 million lei Strategic development 2023 • 2.5MW photovoltaic power station – 26.4% of the annual • New Ointments & Suppositories Plant consumption - € 2,4 million • Research
Slide 14: Antibiotice – a friendly and responsible brand
Write it here Antibiotice – a friendly and responsible brand SUSTAINABILITY • For 20 years, blood donation campaigns – 2,500 people • Human resources saved! development • First-aid training courses for • Center for professional the employees training and development • Vaccination Center a+: • Academ
Slide 15: Antibiotice - a Romanian success story
Write it here Antibiotice - a Romanian success story ✓ Romanian tradition and continuity - The “Industrial and Commercial Merit” Order, the rank of Commander, conferred by the President of Romania - The 1st Place and National Award for 20 consecutive years at the Top National Companies Awards at the
Slide 16: www.antibiotice.ro
Antibiotice err www.antibiotice.ro